First FDA-authorized continuous ketone-and-glucose wearable

The first FDA-authorized wearable to track glucose and ketones continuously may provide earlier warnings of dangerous ketone buildup and DKA than intermittent testing. Its later-2026 launch remains a strong hook, but eligibility, cost, accuracy, alert performance, smartphone integration, and clinical outcomes are unknown; authorization does not establish improved outcomes.